Publications in 2010
Please note: Authors from the Paul-Ehrlich-Institut are highlighted in bold. For online abstracts or full text publications, please follow the links.
Pauli G, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Jansen B, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H, Wirsing von König CH (2010): Orthopox Viruses: Infections in Humans.
Transfus Med Hemother 37: 351-364.
Kloke BP, Schüle S, Mühlebach MD, Wolfrum N, Cichutek K, Schweizer M (2010): Functional HIV-2- and SIVsmmPBj- derived lentiviral vectors generated by a novel polymerase chain reaction-based approach.
J Gene Med 12: 446-452.
Online-Abstract
Binai NA, Damert A, Carra G, Steckelbroeck S, Löwer J, Löwer R, Wessler S (2010): Expression of estrogen receptor alpha increasesleptin-induced STAT3 activity in breast cancer cells.
Int J Cancer 127: 55-66.
Online-Abstract
Zagon J, Jansen B, Knoppik M, Ehlers A, Kroh LW, Holzhauser T, Vieths S, Broll H (2010): Gene transcription analysis of carrot allergens by relative quantification with single and duplex reverse transcription real-time PCR.
Anal Bioanal Chem 396: 483-493.
Online-Abstract
Behrensdorf-Nicol HA, Bonifas U, Kegel B, Silberbach K, Krämer B, Weisser K (2010): In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step.
Toxicol In Vitro 24: 988-94.
Online-Abstract
Jappe U, Vieths S (2010): Lupine, a source of new as well as hidden food allergens.
Mol Nutr Food Res 54: 113-126.
Online-Abstract
Buettner N, Vogt C, Martinez-Sobrido L, Weber F, Waibler Z, Kochs G (2010): Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor.
J Gen Virol 91: 220-227.
Online-Abstract
Kochs G, Bauer S, Vogt C, Frenz T, Tschopp J, Kalinke U, Waibler Z (2010): Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cells.
J Virol 84: 12344-12350.
Online-Abstract
Schüle S, Renner M, Longhurst S, Narayanan G (2010): Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 30-37.
Online-Abstract
Text
Murikinati S, Jüttler E, Keinert T, Ridder DA, Muhammad S, Waibler Z, Ledent C, Zimmer A, Kalinke U, Schwaninger M (2010): Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment.
FASEB J 24: 788-798.
Online-Abstract
Spiczak S von, Helbig I, Keller-Stanislawski B (2010): VACENC: Studie zur wissenschaftlichen Bewertung von Meldungen über epileptische Anfälle und Epilepsien nach Kinderimpfungen.
Bulletin zur Arzneimittelsicherheit 1: 14-15.
Text
Dodt J, Costanzo A, Daas A, Hunfeld A, Buchheit KH (2010): Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
Pharmeur Bio Sci Notes 1: 31-38.
Online-Abstract
Klug B, Reinhardt J, Schröder C (2010): Regelungen zur Überwachung von Wirksamkeit und Sicherheit nach der Zulassung.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 58-62.
Online-Abstract
Text
Pauli G, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H, Wirsing von König CH (2010): Orthopockenviren: Infektionen des Menschen. Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 53: 957-972.
Fulltext
Gehling U, Müller-Berghaus J, Keller-Stanislawski B (2010): Panzytopenie unter Therapie mit RoACTEMRA (Tocilizumab).
Bulletin zur Arzneimittelsicherheit 1: 10-11.
Text
Hoffmann A, Schönborn E, Mergel A, Cußler K (2010): Pharmakovigilanzreport Tierimpfstoffe: Analyse der im Jahr 2008 und 2009 im Paul-Ehrlich-Institut eingegangenen Meldungen.
DTBl: 766-775.
Online-Abstract
Büttel IC, Völler K, Schneider CK (2010): Immunogenicity and its impact on benefit/risk considerations in the authorisation of biopharmaceuticals.
Curr Drug Saf 5: 287-292.
Online-Abstract
Backes S, Sperling KM, Zwilling J, Gasteiger G, Ludwig H, Kremmer E, Schwantes A, Staib C, Sutter G (2010): Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
J Gen Virol 91: 470-482.
Online-Abstract
Kamp C (2010): Untangling the Interplay between Epidemic Spread and Transmission Network Dynamics.
PLoS Comput Biol 6: e1000984.
Text
Ilchmann A, Burgdorf S, Scheurer S, Waibler Z, Nagai R, Wellner A, Yamamoto Y, Yamamoto H, Henle T, Kurts C, Kalinke U, Vieths S, Toda M (2010): Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II.
J Allergy Clin Immunol 125: 175-183.e11.
Online-Abstract
Holznagel E, Yutzy B, Schulz-Schaeffer W, Hanschmann KM, Stuke A, Hahmann U, Törner M, Coulibaly C, Hoffmann A, Hunsmann G, Löwer J (2010): Increase in CD230 (cellular prion protein) fluorescence on blood lymphocytes in bovine spongiform encephalopathy-infected nonhuman primates.
Transfusion 50: 452-466.
Online-Abstract
Grundmann C, Kusch M, Keitel S, Hunfeld A, Breitner-Ruddock S, Seitz R, König H (2010): Modified Thrombin Generation Assay: Application To The Analysis Of Immunoglobulin Concentrates.
WebmedCentral IMMUNOTHERAPY 1: WMC001116.
Online-Abstract
Schweizer M, Merten OW (2010): Large-scale production means for the manufacturing of lentiviral vectors.
Curr Gene Ther 10: 474-486.
Online-Abstract
Henseler O, Heiden M, Haschberger B, Hesse J, Seitz R (2010): Bericht zur Meldung nach § 21 TFG für die Jahre 2008 und 2009.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53: 1089-1103.
Online-Abstract
Text
Pruss A, Caspari G, Krüger DH, Blümel J, Nübling CM, Gürtler L, Gerlich W (2010): Tissue donation and virus safety: more nucleic acid amplification testing is needed.
Transplant Infect Dis 12: 375-386.
Online-Abstract
Heiden M, Seitz R (2010): Pathogen inactivation – regulators aspects.
Vox Sang ISBT Science Series 5: 279-281.
Straßburger J, Meilicke R, Cichutek K (2010): Arzneimittelrechtliche Anforderungen an Arzneimittel für neuartige Therapien aus humanen Pankreata.
MedR 28: 835-841.
Dodt J (2010): Documentation of quality: the Plasma Master File (PMF).
Vox Sang ISBT Science Series 5: 99-100.
Kloft N, Neukirch C, Bobkiewicz W, Veerachato G, Busch T, von Hoven G, Boller K, Husmann M (2010): Pro-autophagic signal induction by bacterial pore-forming toxins.
Med Microbiol Immunol 199: 299-309.
Online-Abstract
Sliva K, Schnierle BS (2010): Selective gene silencing by viral delivery of short hairpin RNA.
Virol J 7: 248.
Online-Abstract
Mühlebach MD, Schaser T, Zimmermann M, Armeanu S, Hanschmann KMO, Cattaneo R, Bitzer M, Lauer UM, Cichutek K, Buchholz CJ (2010): Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus.
Cancer Res 70: 7620-7629.
Online-Abstract
Schottstedt V, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Seitz R, Schlenkrich U, Strobel J, Willkommen H, Wirsing von König H (2010): Humanes Cytomegalievirus (HCMV). Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 53: 973-983.
Fulltext
Hilmenyuk T, Bellinghausen I, Heydenreich B, Ilchmann A, Toda M, Grabbe S, Saloga J (2010): Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells.
Immunology 129: 437-445.
Online-Abstract
Kamp C, Heiden M, Henseler O, Seitz R (2010): Management of blood supplies during an influenza pandemic.
Transfusion 50: 231-239.
Online-Abstract
Kremer M, Sliva K, Klemke CD, Schnierle BS (2010): Cutaneous T-cell lymphoma cells are sensitive to rapamycin.
Exp Dermatol 19: 800-805.
Online-Abstract
Anliker B, Longhurst S, Buchholz CJ (2010): Environmental risk assessment for medicinal products containing genetically modified organisms.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 52-57.
Online-Abstract
Text
Schäd S, Trcka J, Lauer I, Scheurer S, Trautmann A (2010): Wine allergy in a wine-growing district: Tolerance Induction in a patient with allergy to grape lipid-transfer protein.
World Allergy Organiz J 3: 1-5.
Online-Abstract
Sancho AI, Hoffmann-Sommergruber K, Alessandri S, Conti A, Giuffrida MG, Shewry P, Jensen BM, Skov P, Vieths S (2010): Authentication of food allergen quality by physicochemical and immunological methods.
Clin Exp Allergy 40: 973-986.
Online-Abstract
Mühlebach MD, Schüle S, Gerlach N, Schweizer M, Buchholz CJ, Hohenadl C, Cichutek K: Gammaretroviral and Lentiviral Vectors for Gene Delivery.
In: Kurth R, Bannert N (Hrsg.), Retroviruses: Molecular Biology, Genomics and Pathogenesis. Norfolk: Caister Academic Press, 2010. 347-370 ISBN 9781904455554
Jungbäck C, Motitschke A (2010): Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
Biologicals 38: 362-365.
Online-Abstract
Meije Y, Tönjes RR, Fishman JA (2010): Retroviral restriction factors and infectious risk in xenotransplantation.
Am J Transplant 10: 1511-1516.
Online-Abstract
Steckelbroeck, Lütjohann D, Bauman DR, Ludwig M, Friedl A, Hans VH, Penning TM, Klingmüller D (2010): Non-stereo-selective cytosolic human brain tissue 3-ketosteroid reductase is refractory to inhibition by AKR1C inhibitors.
Biochim Biophys Acta 1801: 1221-1231.
Online-Abstract
Cohen-Haguenauer O, Creff N, Cruz P, Tunc C, Aiuti A, Baum C, Bosch F, Blomberg P, Cichutek K, Collins M, Danos O, Dehaut F, Federspiel M, Galun E, Garritsen H, Hauser H, Hildebrandt M, Klatzmann D, Merten OW, Montini E, O'Brien T, Panet A, Rasooly L, Scherman D, Schmidt M, Schweizer M, Tiberghien P, Vandendriessche T, Ziehr H, Ylä-Herttuala S, von Kalle C, Gahrton G, Carrondo M (2010): Relevance of an academic GMP Pan-European vector infra-structure (PEVI).
Curr Gene Ther 10: 414-422.
Online-Abstract
Haschberger B, Hesse J, Heiden M, Seitz R, Schramm W (2010): Dokumentation in der Hämophilietherapie mit Unterstützung des Deutschen Hämophilieregisters.
Hämostaseologie 30: S62-S64.
Online-Abstract
Baylis SA, Nick S, Blümel J, Nübling CM (2010): Hepatitis E virus and blood donors in Germany.
Vox Sang 98: 479.
Online-Abstract
Zwilling J, Sliva K, Schwantes A, Schnierle B, Sutter G (2010): Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Virology 404: 231-239.
Online-Abstract
Weißer K, Heymans L, Keller-Stanislawski B (2010): Anaphylaktische Reaktionen nach Impfung mit Pandemrix (pandemischer H1N1-Impfstoff).
Bulletin zur Arzneimittelsicherheit 1: 4-7.
Text
Röder M, Filbert H, Holzhauser T (2010): A novel, sensitive and specific real-time PCR for the detection of traces of allergenic Brazil nut (Bertholletia excelsa) in processed foods.
Anal Bioanal Chem 398: 2279-2288.
Online-Abstract
Funk MB, Günay S, Lohmann A, Henseler O, Keller-Stanislawski B (2010): Bewertung der Maßnahmen zur Reduktion schwerwiegender Transfusionsreaktionen (Hämovigilanzdaten von 1997 bis 2008).
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 53: 347-356.
Online-Abstract
Text
Meyer H, Weißer K (2010): Gelbfieberimpfung: Impfvirusübertragung von stillenden Müttern auf Säuglinge möglich.
Bulletin zur Arzneimittelsicherheit 1: 14.
Text
Pfleiderer M (2010): Pandemische Influenzaimpfstoffe : Konzepte - Europäische Musterzulassung - Akzeptanzkriterien.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53: 1242-1249.
Text
Johansson T, Broll I, Frenz T, Hemmers S, Becher B, Zeilhofer HU, Buch T (2010): Building a zoo of mice for genetic analyses: a comprehensive protocol for the rapid generation of BAC transgenic mice.
Genesis 48: 264-280.
Online-Abstract
Schumann GG, Gogvadze EV, Osanai-Futahashi M, Kuroki A, Münk C, Fujiwara H, Ivics Z, Buzdin AA (2010): Unique functions of repetitive transcriptomes.
Int Rev Cell Mol Biol 285: 115-188.
Online-Abstract
Neidhart M, Karouzakis E, Schumann GG, Gay RE, Gay S (2010): Trex-1 deficiency in rheumatoid arthritis synovial fibroblasts.
Arthritis Rheum 62: 2673-2679.
Online-Abstract
Gehling U, Tönjes RR, Gerten G (2010): Übertragung einer Amöbeninfektion durch Hornhauttransplantate.
Bulletin zur Arzneimittelsicherheit 1: 7-9.
Text
Vidal JM, Kawabata TT, Thorpe R, Silva-Lima B, Cederbrant K, Poole S, Mueller-Berghaus J, Pallardy M, Van der Laan JW (2010): In vitro cytokine release assays for predicting cytokine release syndrome: the current state-of-the-science. Report of a European Medicines Agency Workshop.
Cytokine 51: 213-215.
Online-Abstract
Prestel J, Mentzer D, Keller-Stanislawski B (2010): Auswertung der UAW-Meldungen nach Impfung mit pandemischen Influenzaimpfstoffen.
Bulletin zur Arzneimittelsicherheit 1: 3-8.
Text
Bayerer B, Engelbergs J, Savidou I, Boes T, Küper M, Schorn CF, Wissmann A, Knop D, Diener HC, Limmroth V (2010): Single nucleotide polymorphisms of the serotonin transporter gene in migraine--an association study.
Headache 50: 319-322.
Online-Abstract
Götz KB, Pfleiderer M, Schneider CK (2010): First-in-human clinical trials with vaccines - what regulators want.
Nat Biotechnol 28: 910-916.
Online-Abstract
Röder M, Baltruweit I, Gruyters H, Ibach A, Mücke I, Matissek R, Vieths S, Holzhauser T (2010): Allergen sanitation in the food industry: a systematic industrial scale approach to reduce hazelnut cross-contamination of cookies.
J Food Prot 73: 1671-1679.
Online-Abstract
Kaul S, Englert L, May S, Vieths S (2010): Regulatory aspects of specific immunotherapy in Europe.
Curr Opin Allergy Immunol 10: 594-602.
Online-Abstract
Sender LY, Gibbert K, Suezer Y, Radeke HH, Kalinke U, Waibler Z (2010): CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals.
Mol Immunol 47: 1255-1261.
Online-Abstract
Le LQ, Mahler V, Scheurer S, Foetisch K, Braun Y, Weigand D, Enrique E, Lidholm J, Paulus KE, Sonnewald S, Vieths S, Sonnewald U (2010): Yeast profilin complements profilin deficiency in transgenic tomato fruits and allows development of hypoallergenic tomato fruits.
FASEB J 24: 4939-4947.
Online-Abstract
Holznagel E, Yutzy B, Löwer J, Schulz-Schaeffer W, Hunsmann G (2010): Three different PrP fractions detectable on simian white blood cells.
Transfusion 50: 2065-2066.
Baylis SA, Blümel J (2010): Regulatory expectations of validation/qualification of adventitious virus assays.
PDA J Pharm Sci Technol 64: 486-491.
Online-Abstract
Kamp C, Wolf T, Bravo IG, Kraus B, Krause B, Neumann B, Winskowsky G, Thielen A, Werner A, Schnierle BS (2010): Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report.
Virol J 7: 55.
Volltext
Frenz T, Waibler Z, Hofmann J, Hamdorf M, Lantermann M, Reizis B, Tovey MG, Aichele P, Sutter G, Kalinke U (2010): Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.
Eur J Immunol 40: 2769-2777.
Online-Abstract
Zoccatelli G, Pokoj S, Foetisch K, Bartra J, Valero A, Del Mar San Miguel-Moncin M, Vieths S, Scheurer S (2010): Identification and characterization of the major allergen of green bean (Phaseolus vulgaris) as a non-specific lipid transfer protein (Pha v 3).
Mol Immunol 47: 1561-1568.
Online-Abstract
Eis-Hübinger AM, Drexler JF, Reber U, Panning M, Drosten C, Weber-Schehl M, Hedges D, Baylis SA, Roth WK (2010): Absence of detection of novel human parvoviruses in German plasma donations.
Transfusion 50: 266-267.
Seitz R, Heiden M, Funk M, Keller-Stanislawski B, Cichutek K (2010): Die Rolle des Paul-Ehrlich-Instituts im Transfusionswesen.
Hämotherapie 14: 69-73.
Pokoj S, Lauer I, Fötisch K, Himly M, Mari A, Enrique E, Miguel-Moncin MS, Lidholm J, Vieths S, Scheurer S (2010): Pichia pastoris is superior to E. coli for the production of recombinant allergenic non-specific Lipid Transfer Proteins.
Protein Expr Purif 69: 68-75.
Online-Abstract
Wagner R: Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks.
World Health Organization (Hrsg.), Geneva: WHO Press, 2010
Hartz C, Lauer I, del Mar San Miguel-Moncín M, Cisteró-Bahíma A, Fötisch K, Lidholm J, Vieths S, Scheurer S (2010): Comparison of IgE-binding capacity, cross-reactivity and biological potency of allergenic non-specific lipid transfer proteins from peach, cherry and hazelnut.
Int Arch Allergy Immunol 153: 335-346.
Online-Abstract
Holzhauser T, Röder M: Allergens in tree nuts, sesame seeds, mustard, and celery.
In: Nollet LML, van Hengel AJ, (Hrsg.), Food Allergens – Analysis, Instrumentation and Methods. Boca Raton: CRC Press, 2010. S. 77-128 ISBN 978-1-4398-1503-8
Kern M, Popov A, Scholz K, Schumak B, Djandji D, Limmer A, Eggle D, Sacher T, Zawatzky R, Holtappels R, Reddehase MJ, Hartmann G, Debey-Pascher S, Diehl L, Kalinke U, Koszinowski U, Schultze J, Knolle PA (2010): Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity.
Gastroenterology 138: 336-346.
Online-Abstract
Perkovic M, Norley S, Sanzenbacher R, Battenberg M, Panitz S, Coulibaly C, Flory E, Siegismund C, Münk C, Cichutek K (2010): SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenic.
Virology 399: 87-97.
Online-Abstract
Seitz R, Heiden M (2010): Quality and Safety in Blood Supply in 2010.
Tranfus Med Hemother 37: 112-117.
Online-Abstract
Berger A, Münk C, Schweizer M, Cichutek K, Schüle S, Flory E (2010): Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes.
J Biol Chem 285: 12248-54.
Online-Abstract
Kreijtz JH, Süzer Y, Bodewes R, Schwantes A, van Amerongen G, Verburgh RJ, de Mutsert G, van den Brand J, van Trierum SE, Kuiken T, Fouchier RA, Osterhaus AD, Sutter G, Rimmelzwaan GF (2010): Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.
J Gen Virol 91: 2745-2752.
Online-Abstract
Baylis SA, Chudy M, Blümel J, Pisani G, Candotti D, José M, Heath AB (2010): Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Vox Sang 98: 441-446.
Online-Abstract
Heinig L, Mueller DA, Ramljak S, Holznagel E, Stuke AW (2010): Inducible expression of chimpanzee prion protein (PrP) in murine PrP knock-out cells.
Protein Expr Purif 70: 129-136.
Online-Abstract
Salmikangas P, Flory E, Reinhardt J, Hinz T, Maciulaitis R (2010): Regulatory requirements for clinical trial and marketing authorisation application for cell-based medicinal products.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 24-29.
Online-Abstract
Text
Blümel J, Stühler A (2010): Wichtige Aspekte der Virussicherheit bei Neuartigen Therapien.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 38-44.
Online-Abstract
Text
Hrincius ER, Wixler V, Wolff T, Wagner R, Ludwig S, Ehrhardt C (2010): CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses.
Cell Microbiol 12: 831-843.
Online-Abstract
Löwer J (2010): Pandemieimpfstoffe - Überlegungen zum Design im Vorfeld der Influenzapandemie 2009.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53: 1238-1241.
Text
Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Ancans J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS, Moraru AS, Turcáni P, Zorec R, Ruiz S, Akerblom L, Narayanan G, Kent A, Bignami F, Dickson JG, Niederwiseser D, Figuerola-Santos MA, Reischl IG, Beuneu C, Georgiev R, Vassiliou M, Pychova A, Clausen M, Methuen T, Lucas S, Schüssler-Lenz M, Kokkas V, Buzás Z, MacAleenan N, Galli MC, Line A, Gulbinovic J, Berchem G, Fraczek M, Menezes-Ferreira M, Vilceanu N, Hrubisko M, Marinko P, Timón M, Cheng W, Crosbie GA, Meade N, di Paola ML, VandenDiressche T, Ljungman P, D'Apote L, Oliver-Diaz O, Büttel I, Celis P (2010): Challenges with advanced therapy medicinal products and how to meet them.
Nat Rev Drug Discov 9: 195-201.
Online-Abstract
Cichutek K, Granzer U (2010): Der Rahmen ist gesetzt: Fortschritte bei Gen-, Zelltherapeutika und Tissue Engineering-Arzneimitteln.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 1-3.
Online-Abstract
Text
Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A (2010): Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.
Vox Sang 98: 403-414.
Online-Abstract
Motitschke A, Ottiger HP, Jungbäck C (2010): Evaluation of the sensitivity of PCR methods for the detection of extraneous agents and comparison with in vivo testing.
Biologicals 38: 389-392.
Online-Abstract
Henseler O, Heiden M, Haschberger B, Hesse J, Seitz R (2010): Report on Notifications Pursuant to §21 German Transfusion Act for 2007.
Transfus Med Hemother 37: 29-47.
Online-Abstract
Lempereur L, Mathys E, Minor P, Pini C, Unkelbach U, Vitkova E: Official Control Authority Batch Release of Clotting Factor Concentrates, Plasma Inhibitor Concentrates and Fibrin Sealants.
EDQM (Hrsg.), 15th Annual Meeting of the Official Medicines Control Laboratories (OMCL) Network Split, Croatia, 2010
Keiner B, Maenz B, Wagner R, Cattoli G, Capua I, Klenk HD (2010): Intracellular distribution of NS1 correlates with the infectivity and interferon antagonism of an avian influenza virus (H7N1).
J Virol 84: 11858-11865.
Online-Abstract
Banaz-Yasar F, Steffen G, Hauschild J, Bongartz BM, Schumann GG, Ergün S (2010): LINE-1 retrotransposition events affect endothelial proliferation and migration.
Histochem Cell Biol 134: 581-589.
Online-Abstract
Ruoff C: § 31 Sera und Impfstoffe.
In: Fuhrmann S, Klein B (Hrsg.), Arzneimittelrecht - Handbuch für die pharmazeutische Rechtspraxis. 1. Aufl. Baden-Baden: Nomos, 2010. 977-988 ISBN 978-3832951597
Gadermaier G, Jahn-Schmid B, Vogel L, Egger M, Himly M, Briza P, Ebner C, Vieths S, Bohle B, Ferreira F (2010): Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy.
Mol Immunol 47: 1292-1298.
Online-Abstract
Tchaptchet S, Kirberg J, Freudenberg N, Schamel WW, Galanos C, Freudenberg MA (2010): Innate, antigen-independent role for T cells in the activation of the immune system by Propionibacterium acnes.
Eur J Immunol 40: 2506-2516.
Online-Abstract
Fiocchi A, Brozek J, Schünemann H, Bahna SL, von Berg A, Beyer K, Bozzola M, Bradsher J, Compalati E, Ebisawa M, Guzmán MA, Li H, Heine RG, Keith P, Lack G, Landi M, Martelli A, Rancé F, Sampson H, Stein A, Terracciano L, Vieths S, World Allergy Organization (WAO) Special Committee on Food Allergy (2010): World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.
Pediatr Allergy Immunol 21: 1-125.
Muthuswamy R, Mueller-Berghaus J, Haberkorn U, Reinhart TA, Schadendorf D, Kalinski P (2010): PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.
Blood 116: 1454-1459.
Online-Abstract
Stammschulte T, Pachl H, Gundert-Remy U, Lütkehermölle W, Paeschke N, Volz-Zang C, Keller-Stanislawski B (2010): Einführung in die Grundlagen der Pharmakovigilanz (Teil II): Spontanmeldesystem zur Erfassung von Verdachtsfällen unerwünschter Arzneimittelwirkungen (UAW).
Bulletin zur Arzneimittelsicherheit 1: 18-26.
Text
Denner J, Tönjes RR (2010): Berlin Symposium on Xenotransplantation, German DFG-Transregio Research Group Xenotransplantation together with the 12th Minisymposium Xenotransplantation of the German Working Group Xenotransplantation (DAX), June 4-5, 2009, Robert Koch Institut, Berlin.
Xenotransplantation 17: 94-120.
Schottstedt V, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Seitz R, Schlenkrich U, Strobel J, Willkommen H, Wirsing von König H (2010): Human Cytomegalovirus (HCMV) – Revised.
Transfusion Med Hemother 37: 365-375.
Harrer A, Lang R, Grims R, Braitsch M, Hawranek T, Aberer W, Vogel L, Schmid W, Ferreira F, Himly M (2010): Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites.
PLoS One 5: e13707.
Text
Oberle D, Pönisch C, Paeschke N, Lehmann B, Mentzer D (2010): Pharmakovigilanz bei Kindern.
Bulletin zur Arzneimittelsicherheit 1: 16-18.
Text
Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Pauli G, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H, Wirsing von König CH (2010): Parvovirus B19 – Revised.
Transfus Med Hemother 37: 339-350.
Kanse SM, Etscheid M (2010): Factor VII activating protease (FSAP): caught in the cross-fire between polycations and polyanions.
J Thromb Haemost 8: 556-558.
Schülke S, Waibler Z, Mende S, Zoccatelli G, Vieths S, Toda M, Scheurer S (2010): Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC.
Mol Immunol 48: 341-350.
Online-Abstract
Hsu SC, Chen CH, Tsai SH, Kawasaki H, Hung CH, Chu YT, Chang HW, Zhou Y, Fu J, Plunkett B, Su SN, Vieths S, Lee RT, Lee YC, Huang SK (2010): Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells.
J Biol Chem 285: 7903-7910.
Online-Abstract
Kamp C (2010): Demographic and behavioural change during epidemics : International Conference on Computational Science, ICCS 2010.
Procedia Computer Science 1: 2247-2253.
Online-Abstract
Oberle D, Weißer K, Keller-Stanislawski B (2010): Aktuelle Erkenntnisse zum Risiko für Invagination und Kawasaki-Syndrom nach Rotavirusimpfung.
Bulletin zur Arzneimittelsicherheit 1: 8-13.
Text
Pfleiderer M, Keller-Stanislawski B (2010): Saisonaler Grippeimpfstoff Afluria 2010/2011: erhöhte Melderate von Fieber und Fieberkrämpfen bei Kindern unter fünf Jahren in Australien.
Bulletin zur Arzneimittelsicherheit 1: 9-10.
Text
Weißer K, Mentzer D, Volkers P, Keller-Stanislawski B (2010): PML nach Behandlung mit Natalizumab (Tysabri) bei Patienten mit multipler Sklerose.
Bulletin zur Arzneimittelsicherheit 1: 8-11.
Text
Hergert P: § 32 Blut und Blutprodukte.
In: Fuhrmann S, Klein B (Hrsg.), Arzneimittelrecht - Handbuch für die pharmazeutische Rechtspraxis. 1. Aufl. Baden-Baden: Nomos, 2010. 989-1006 ISBN 978-3832951597
Reiss M: Prozessmanagement im Hospiz.
München: GRIN, 2010. 25 S. ISBN 978-3-640-58937-1
Seitz R, Krause G (2010): Pandemien: Was haben wir aus der H1N1-Influenza gelernt?.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 53: 1221-1222.
Fulltext
Keller-Stanislawski B, Reil A, Günay S, Funk MB (2010): Frequency and severity of transfusion-related acute lung injury - German haemovigilance data (2006-2007).
Vox Sang 98: 70-77.
Online-Abstract
Anliker B, Abel T, Kneissl S, Hlavaty J, Caputi A, Brynza J, Schneider IC, Muench RC, Petznek H, Kontermann RE, Koehl U, Johnston ICD, Keinänen K, Müller UC, Hohenadl C, Monyer H, Cichutek K, Buchholz CJ (2010): Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.
Nat Methods 7: 929-935.
Online-Abstract
Moussawi KA, Ghigo E, Kalinke U, Alexopoulou L, Mege JL, Desnues B (2010): Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei.
PLoS Pathog 6: e1000722.
Fulltext
Montag T, Störmer M, Schurig U, Brachert J, Bubenzer M, Sicker U, Beshir R, Spreitzer I, Löschner B, Bache C, Becker B, Schneider CK (2010): Probleme der mikrobiellen Sicherheit bei neuartigen Therapien.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 45-51.
Online-Abstract
Text
Schüßler-Lenz M, Schneider CK (2010): Klinische Prüfung mit Arzneimitteln für Neuartige Therapien.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 53: 68-74.
Online-Abstract
Text
Dervillez X, Klaukien V, Dürr R, Koch J, Kreutz A, Haarmann T, Stoll M, Lee D, Carlomagno T, Schnierle B, Möbius K, Königs C, Griesinger C, Dietrich U (2010): Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
J Virol 84: 10131-10138.
Online-Abstract
Bublin M, Pfister M, Radauer C, Oberhuber C, Bulley S, Dewitt AM, Lidholm J, Reese G, Vieths S, Breiteneder H, Hoffmann-Sommergruber K, Ballmer-Weber BK (2010): Component-resolved diagnosis of kiwifruit allergy with purified natural and recombinant kiwifruit allergens.
J Allergy Clin Immunol 125: 687-694.e1.
Online-Abstract